Testing Before Treating: Molecular Determinants of Optimal Therapy for NSCLC

Learn how experts test for biomarkers in patients with NSCLC with multidisciplinary perspectives from a medical oncologist and a pathologist toward the optimal care of patients with NSCLC including a downloadable slideset from the live webinar a focused text-based module and expert-authored commentaries on optimal biomarker testing to guide treatment for patients with NSCLC.

Share

Program Content

Activities

Biomarker Testing in NSCLC
Biomarker Testing to Optimize NSCLC Care: Multidisciplinary Perspectives
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: July 06, 2022

Expires: July 05, 2023

Slides: Biomarker Testing in NSCLC
Biomarker Testing in NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 06, 2022

Expires: July 05, 2023

Activities

NSCLC: Testing and Treating
Testing Before Treating: Molecular Determinants of Optimal Therapy for NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 29, 2022

Expires: July 28, 2023

Activities

NSCLC: Current and Emerging Testing
What Must Be Tested in NSCLC Today and Likely Tomorrow
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 11, 2022

Expires: July 10, 2023

FAQs: Biomarker Testing in NSCLC
FAQs: Importance of Biomarker Testing in NSCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 31, 2022

Expires: August 30, 2023

NSCLC: Trastuzumab Deruxtecan
Trastuzumab Deruxtecan for Our Patients With HER2 Mutation–Positive Advanced NSCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 12, 2022

Expires: September 11, 2023

NSCLC: Experts Address FAQs
FAQs: New Directions in Biomarker Testing in the Management of NSCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 17, 2022

Expires: October 16, 2023

Activities

Biomarker Testing in NSCLC: Infographic
Testing Before Treating: Biomarkers for Selecting Optimal Therapy for NSCLC
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: August 24, 2022

Expires: August 23, 2023

Faculty

cover img faculity

Matthew Gubens, MD, MS

Associate Professor
Thoracic Oncology
University of California, San Francisco
San Francisco, California

cover img faculity

Alexander Craig Mackinnon, Jr., MD, PhD, MSHA

Robert B. Adams Endowed Professor
Professor and Director, Division of Genomic Diagnostics & Bioinformatics
Department of Pathology
The University of Alabama at Birmingham Heersink School of Medicine
Birmingham, Alabama

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Bayer Healthcare Pharma

Daiichi Sankyo, Inc.

Genentech TEXT Only

Janssen administered by Scientific Affairs

Lilly

Novartis Pharmaceuticals Corporation

Partners

AMP

ProCE Banner